True Wealth Design LLC Buys Shares of 1,946 Sotera Health (NASDAQ:SHC)

True Wealth Design LLC purchased a new position in Sotera Health (NASDAQ:SHC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,946 shares of the company’s stock, valued at approximately $32,000.

Several other large investors also recently modified their holdings of SHC. William Blair Investment Management LLC increased its holdings in Sotera Health by 0.6% during the second quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company’s stock valued at $13,430,000 after buying an additional 6,707 shares during the last quarter. Clearline Capital LP purchased a new stake in shares of Sotera Health in the 2nd quarter worth $1,707,000. First Pacific Advisors LP bought a new position in Sotera Health in the 2nd quarter worth $540,000. Darsana Capital Partners LP purchased a new position in Sotera Health during the second quarter valued at $29,074,000. Finally, Bank of New York Mellon Corp grew its holdings in Sotera Health by 3.9% during the second quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company’s stock valued at $11,918,000 after purchasing an additional 37,681 shares during the period. Institutional investors own 91.03% of the company’s stock.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now directly owns 49,215,301 shares in the company, valued at $739,705,974.03. This trade represents a 16.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 55.12% of the stock is currently owned by company insiders.

Sotera Health Price Performance

Shares of Sotera Health stock opened at $13.17 on Monday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a 50 day moving average price of $15.25 and a 200-day moving average price of $14.04. The stock has a market cap of $3.73 billion, a price-to-earnings ratio of 52.68 and a beta of 2.08. Sotera Health has a one year low of $10.71 and a one year high of $17.44.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. During the same quarter last year, the business posted $0.18 EPS. Sotera Health’s revenue was up 8.5% compared to the same quarter last year. Equities analysts expect that Sotera Health will post 0.61 EPS for the current year.

Wall Street Analyst Weigh In

SHC has been the topic of several recent research reports. Citigroup raised their price objective on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. Barclays lifted their price target on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $16.50.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.